Muthusamy Saravanaraja, Subhawong Ty, Conway Sheila A, Temple H Thomas
Department of Orthopaedic Surgery, University of Miami Miller School of Medicine, 1400 NW 12th Avenue, Miami, FL, USA,
Clin Orthop Relat Res. 2015 Feb;473(2):742-50. doi: 10.1007/s11999-014-3926-x. Epub 2014 Sep 12.
Fibrous dysplasia is a benign fibroosseous bone tumor that accounts for 5% to 10% of benign bone tumors. It can present as monostotic fibrous dysplasia (70% to 80%), polyostotic fibrous dysplasia (20% to 30%), McCune-Albright syndrome (2% to 3%), or Mazabraud's syndrome in rare cases. Bone lesions in fibrous dysplasia arise in the medullary canal and usually are confined to the bone. Cortical destruction and extension into soft tissue usually indicates malignant transformation or secondary aneurysmal bone cyst formation. Locally aggressive fibrous dysplasia with cortical destruction and extension into soft tissue in the absence of these two possibilities is extremely rare. It is important for the treating physician to distinguish this entity from more aggressive or malignant tumors to avoid overtreating the patient for a benign condition or inattention to a malignant tumor.
We report four unusual cases of fibrous dysplasia with an aggressive radiographic appearance. They occurred in the rib (1), ilium (2), and distal femur (1). Two patients had pain and two had swelling. Radiologically, all were associated with cortical destruction and an associated soft tissue mass, and initially they were interpreted as potentially malignant. Three patients underwent biopsy and one patient did not have a biopsy. Histopathologic analysis by an experienced bone pathologist confirmed fibrous dysplasia in all patients. Two patients were treated surgically; one patient with zoledronic acid and one patient currently is being followed by observation alone.
There are only a few reports in the literature that describe the locally aggressive variant of fibrous dysplasia that presents with pain and progressive swelling clinically and with cortical destruction and soft tissue extension on imaging which suggest malignancy. We could not find any article that describes the use of bisphosphonates in such lesions or the response to bisphosphonates clinically, on laboratory parameters or imaging. To our knowledge, this is the largest case report published regarding locally aggressive fibrous dysplasia arising outside the craniofacial skeleton.
The locally aggressive variant of fibrous dysplasia may be confused with a malignant tumor or malignant degeneration of fibrous dysplasia. It is important to properly evaluate these lesions to ensure that a proper diagnosis is made, especially with respect to a malignant versus benign mass.
骨纤维异常增殖症是一种良性纤维骨性骨肿瘤,占良性骨肿瘤的5%至10%。它可表现为单骨型骨纤维异常增殖症(70%至80%)、多骨型骨纤维异常增殖症(20%至30%)、McCune - Albright综合征(2%至3%),罕见情况下为马扎布罗德综合征。骨纤维异常增殖症的骨病变起源于髓腔,通常局限于骨内。皮质破坏并延伸至软组织通常提示恶性转化或继发性动脉瘤样骨囊肿形成。在不存在这两种可能性的情况下,具有皮质破坏并延伸至软组织的局部侵袭性骨纤维异常增殖症极为罕见。对于治疗医生而言,将此实体与更具侵袭性或恶性的肿瘤区分开来很重要,以免因良性疾病过度治疗患者或忽视恶性肿瘤。
我们报告了4例具有侵袭性影像学表现的骨纤维异常增殖症不寻常病例。它们分别发生于肋骨(1例)、髂骨(2例)和股骨远端(1例)。2例患者有疼痛,2例有肿胀。放射学检查显示,所有病例均伴有皮质破坏及相关软组织肿块,最初被解读为可能为恶性。3例患者接受了活检,1例未进行活检。一位经验丰富的骨病理学家进行的组织病理学分析证实所有患者均为骨纤维异常增殖症。2例患者接受了手术治疗;1例患者接受唑来膦酸治疗,1例患者目前仅通过观察随访。
文献中仅有少数报道描述了骨纤维异常增殖症的局部侵袭性变体,其临床症状为疼痛和进行性肿胀,影像学表现为皮质破坏和软组织延伸,提示恶性。我们未找到任何描述在此类病变中使用双膦酸盐或双膦酸盐临床疗效、实验室参数或影像学表现的文章。据我们所知,这是关于颅面骨骼外发生的局部侵袭性骨纤维异常增殖症发表的最大病例报告。
骨纤维异常增殖症的局部侵袭性变体可能与恶性肿瘤或骨纤维异常增殖症的恶性变相混淆。正确评估这些病变以确保做出正确诊断很重要,尤其是区分恶性与良性肿块。